Leadership Overview
SAMSUNG BIOLOGICS has 4 executives leading key functions including information technology, global marketing, financial operations, and cell culture engineering.
Focused on advancing global biopharmaceutical manufacturing, SAMSUNG BIOLOGICS delivers high-quality CDMO services while maintaining a commitment to innovation, operational excellence, and the rapid development of life-saving therapeutic products for international markets.
Focused on advancing global biopharmaceutical manufacturing, SAMSUNG BIOLOGICS delivers high-quality CDMO services while maintaining a commitment to innovation, operational excellence, and the rapid development of life-saving therapeutic products for international markets.
Leadership Roles at SAMSUNG BIOLOGICS
Seungho Ryu - Executive Vice President & Head Chief Financial Officer, The Business Support Center
Seungho Ryu, the Executive Vice President & Head Chief Financial Officer, The Business Support Center at SAMSUNG BIOLOGICS, manages the financial health and resource allocation for large-scale biopharmaceutical operations. Overseeing the Business Support Center, the Executive Vice President & Head Chief Financial Officer, The Business Support Center directs capital budgeting for facility expansion and advanced analytical testing equipment. This leadership role involves monitoring fiscal performance across the CDMO and Biopharmaceutical Development segments to ensure profitability. By optimizing cost structures for clinical manufacturing and biosimilar drug research, Ryu supports the overall financial stability of the organization. The Executive Vice President & Head Chief Financial Officer, The Business Support Center collaborates with other executives to evaluate investment risks associated with international market entry. Through rigorous financial oversight, Seungho Ryu maintains the fiscal discipline required to fund ongoing innovation in antibody-drug conjugates and other complex therapeutic development projects.
Jae Lee - Chief Information Officer
Jae Lee, the Chief Information Officer at SAMSUNG BIOLOGICS, directs the digital transformation of complex biopharmaceutical manufacturing processes. Overseeing the integration of advanced data analytics and secure cloud infrastructure, the Chief Information Officer ensures seamless connectivity across global production facilities. This leadership role involves architecting robust cybersecurity frameworks to protect proprietary cell line development data and clinical manufacturing records. By implementing automated systems for quality assurance and biosafety testing, Lee optimizes operational efficiency across the entire CDMO value chain. The Chief Information Officer collaborates with the Board to align technological investments with long-term growth objectives in the United States and Europe. Through the deployment of sophisticated enterprise resource planning tools, Lee enhances supply chain visibility and manufacturing precision. Ultimately, Jae Lee secures the digital foundation necessary for maintaining the competitive edge of the company in the international biopharmaceutical market.
James Choi - Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs
James Choi, the Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs at SAMSUNG BIOLOGICS, drives the commercial strategy for contract development and manufacturing services. Overseeing global market expansion, the Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs manages relationships with international pharmaceutical partners to secure long-term manufacturing contracts. This leadership role involves coordinating public affairs initiatives to strengthen the corporate brand across South Korea, Europe, and the United States. By aligning sales support functions with client needs for aseptic filling and lyophilization services, Choi ensures consistent revenue growth. The Executive Vice President & Head Chief Marketing Officer, Sales Support & Global Public Affairs works closely with the C-suite to communicate the value proposition of mammalian and mRNA product manufacturing capabilities. Through strategic market positioning, James Choi expands the reach of the company, ensuring sustained commercial success in the competitive global biopharmaceutical landscape.
Jiye Nam - Engineer- Chief Marketing Officer, Cell Culture
Jiye Nam, the Engineer- Chief Marketing Officer, Cell Culture at SAMSUNG BIOLOGICS, architects the technical marketing strategy for specialized cell line development and process optimization services. Overseeing the technical interface between engineering teams and potential clients, the Engineer- Chief Marketing Officer, Cell Culture translates complex scientific capabilities into actionable manufacturing solutions. This leadership role involves promoting the expertise of the company in mammalian cell culture to attract high-value biopharmaceutical partners. By highlighting the precision of discovery and process development services, Nam drives demand for the advanced manufacturing facilities. The Engineer- Chief Marketing Officer, Cell Culture works with the R&D department to ensure that marketing materials accurately reflect the latest breakthroughs in biosafety and analytical testing. Through technical leadership, Jiye Nam positions the company as a premier partner for complex drug development, directly influencing the acquisition of new clinical manufacturing projects across global markets.
Explore Leadership Teams in Manufacturing
Bayer is a global enterprise in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. They have divisions in pharmaceuticals, crop science, animal health, and consumer health. Bayer is headquartered in Leverkusen, Germany.
Company Leadership LR
PG
BC
Abdi Ibrahim provides pharmaceutical services to the healthcare sector that are beneficial in maintaining people's health. Abdi Ibrahim was founded in 1912 and is based in Istanbul, Turkey.
Company Leadership GO
MÇ
Tabuk Pharmaceuticals is a generic pharmaceutical company that delivers quality cost-effective prices in the regulated markets of the MENA region. The company provides to the major therapeutic areas of GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and the central nervous system pharmaceuticals.
Company Leadership IS
DB
HR

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
Company Leadership CD
CL
CW
QW